◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
奥泰生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016
+Revenue 867.0M 755.0M 3.4B 1.9B 1.1B 241.0M 184.0M 130.0M 75.7M
Revenue Growth % 14.8% -77.7% 80.9% 64.9% 371.4% 31.0% 41.5% 71.7% --
Total Revenue 867.0M 755.0M 3.4B 1.9B 1.1B 241.0M 184.0M 130.0M 75.7M
Cost Of Revenue 384.0M 387.0M 1.4B 840.0M 202.0M 91.0M 68.3M 47.8M 30.9M
+Gross Profit 483.0M 368.0M 2.0B 1.0B 934.0M 150.0M 115.7M 82.2M 44.8M
Gross Margin % 55.7% 48.7% 59.9% 55.2% 82.2% 62.2% 62.9% 63.2% 59.2%
Total Operating Cost 589.0M 598.0M 2.0B 1.0B 351.0M 162.0M 122.0M 93.1M 58.2M
Selling Expenses 55.4M 69.3M 150.0M 49.8M 33.1M 17.1M 9.8M 8.7M 5.2M
Admin Expenses 64.8M 66.6M 78.1M 32.7M 25.0M 16.0M 8.0M 7.5M 3.2M
Rd Expenses 95.8M 121.0M 207.0M 95.5M 55.1M 35.9M 30.9M 25.9M 20.1M
Finance Expenses -37.4M -58.5M -70.9M -17.7M 18.6M -1.2M -2.2M 1.6M -2.6M
+Operating Income 346.0M 212.0M 1.4B 897.0M 793.0M 88.1M 62.5M 37.8M 17.5M
Operating Margin % 39.9% 28.1% 41.1% 47.9% 69.8% 36.6% 34.0% 29.1% 23.1%
Non Operating Income 3.2M 24,100 125,200 58,300 11,900 11,100 18,200 84,800 525,500
Non Operating Expenses 990,900 14.2M 12.5M 1.3M 1.1M 166,300 11,000 18,100 43,500
Investment Income 12.2M 8.6M 24.1M 7.0M 5.2M 1.3M 33,100 -- --
Fair Value Change Income 35.5M 32.7M -15.2M 21.3M -- -- -- -- --
Asset Disposal Income 1.2M -419,200 533,200 -59,000 -- 306,000 -- -- --
Asset Impairment Loss 9.1M -5.6M 280.0M 3.9M 2.6M -2.4M 4.6M 735,500 1.1M
Other Income 18.8M 13.7M 31.8M 15.9M 3.1M 7.7M 502,000 1.1M --
Income Before Tax 348.0M 197.0M 1.4B 896.0M 792.0M 88.0M 62.5M 37.8M 17.9M
Income Tax 44.8M 17.2M 196.0M 130.0M 112.0M 9.5M 6.1M 3.6M 2.6M
+Net Income 303.0M 180.0M 1.2B 766.0M 679.0M 78.4M 56.4M 34.2M 15.3M
Net Margin % 34.9% 23.8% 35.0% 40.9% 59.8% 32.5% 30.7% 26.3% 20.3%
Net Income Attributable 302.0M 181.0M 1.2B 766.0M 679.0M 78.4M 56.4M 34.2M 15.2M
Minority Interest 437,900 -295,600 538,000 -- -- -- -- 68,200 120,800
Eps Basic 3.82 2.28 14.95 15.15 16.82 1.94 1.43 0.88 1.27
Eps Diluted 3.82 2.28 14.95 -- -- -- 1.43 0.88 1.22
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016
Cash And Equivalents 920.0M 1.3B 2.0B 2.2B 286.0M 63.3M 11.9M 43.3M 7.9M
Trading Financial Assets 1.7B 1.5B 1.8B 780.0M 415.0M 62.0M -- -- --
Accounts Receivable 124.0M 101.0M 139.0M 208.0M 163.0M 53.2M 67.7M 29.5M --
Notes Receivable 792,000 -- -- -- -- -- -- -- --
Notes And Accounts Receivable 125.0M 101.0M 139.0M 208.0M 163.0M 53.2M 67.7M 29.5M 25.8M
Prepayments 13.7M 13.1M 22.1M 30.8M 17.3M 900,300 2.7M 66,600 125,500
Inventory 160.0M 189.0M 194.0M 384.0M 124.0M 54.5M 42.6M 28.8M 18.5M
Total Current Assets 3.0B 3.2B 4.2B 3.7B 1.0B 239.0M 171.0M 111.0M 55.0M
Long Term Equity Investment 41.6M -- -- -- -- -- -- -- --
Fixed Assets -- 249.0M 250.0M 98.6M 55.2M 51.9M 43.3M 44.1M --
Fixed Assets Total 439.0M 249.0M 250.0M 98.6M 55.2M 51.9M 43.3M 44.1M 2.6M
Construction In Progress -- 488.0M 42.3M 82.4M 11.6M -- 2.0M -- --
Construction In Progress Total 460.0M 488.0M 42.3M 82.4M 11.6M -- 2.0M -- --
Intangible Assets 105.0M 110.0M 93.0M 28.1M 28.8M 15.9M 16.3M 16.6M --
Long Term Deferred Expenses 10.3M 15.7M 17.9M 5.7M 2.2M 2.3M 2.6M 1.1M 1.0M
Total Non Current Assets 1.2B 955.0M 506.0M 340.0M 126.0M 93.0M 83.3M 79.7M 4.8M
Total Assets 4.2B 4.1B 4.7B 4.0B 1.2B 333.0M 255.0M 191.0M 59.7M
Accounts Payable 105.0M 77.6M 171.0M 361.0M 62.0M 16.6M 21.3M 40.5M --
Advance Receipts 515,300 -- -- -- -- 8.5M 6.3M 2.9M 2.1M
Contract Liabilities 40.8M 41.6M 147.0M 226.0M 33.4M -- -- -- --
Total Current Liabilities 299.0M 274.0M 511.0M 714.0M 178.0M 39.3M 39.5M 52.0M 32.4M
Total Non Current Liabilities 3.4M 10.3M 13.4M 20.5M -- -- -- -- --
Total Liabilities 303.0M 284.0M 524.0M 735.0M 178.0M 39.3M 39.5M 52.0M 32.4M
Paid In Capital 79.3M 79.3M 53.9M 53.9M 40.4M 40.4M 40.4M 39.0M 12.0M
Capital Reserve 1.7B 1.7B 1.7B 1.7B 103.0M 103.0M 103.0M 84.0M 2.7M
Surplus Reserve 266.0M 266.0M 248.0M 161.0M 82.9M 14.9M 7.3M 1.9M 1.5M
Retained Earnings 1.9B 1.8B 2.2B 1.3B 746.0M 135.0M 64.7M 13.6M 11.0M
Minority Equity -220,900 4.3M 4.4M -- -- -- -- -- 156,900
Equity Attributable 3.9B 3.8B 4.2B 3.3B 973.0M 293.0M 215.0M 139.0M 27.2M
Total Equity 3.9B 3.8B 4.2B 3.3B 973.0M 293.0M 215.0M 139.0M 27.3M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016
Cash From Sales 860.0M 687.0M 3.5B 2.0B 1.1B 257.0M 149.0M 125.0M 55.9M
Tax Refunds Received 33.5M 25.8M 202.0M 69.1M 24.4M 21.4M 13.3M 7.7M 6.6M
Total Operating Cash Inflow 947.0M 780.0M 3.8B 2.1B 1.1B 286.0M 164.0M 134.0M 63.1M
Cash Paid For Goods 329.0M 421.0M 1.7B 846.0M 261.0M 97.5M 83.9M 57.5M 27.6M
Cash Paid To Employees 165.0M 165.0M 194.0M 113.0M 63.9M 46.4M 36.0M 27.4M 16.0M
Taxes Paid 41.6M 41.1M 288.0M 135.0M 74.9M 21.7M 9.7M 9.1M 917,600
Total Operating Cash Outflow 618.0M 755.0M 2.4B 1.2B 464.0M 195.0M 145.0M 114.0M 56.4M
Operating Cash Flow 330.0M 24.8M 1.4B 924.0M 623.0M 91.5M 18.6M 20.0M 6.7M
Total Investing Cash Inflow 2.4B 1.8B 2.3B 788.0M 430.0M 127.0M 10.0M -- --
Total Investing Cash Outflow 2.9B 1.9B 3.5B 1.3B 815.0M 167.0M 79.7M 52.1M 2.1M
Investing Cash Flow -479.0M -141.0M -1.3B -531.0M -385.0M -40.4M -69.6M -52.1M -2.1M
Dividends And Interest Paid 233.0M 529.0M 216.0M 108.0M -- -- -- -- --
Total Financing Cash Inflow 9.0M 8.9M 3.7M 1.7B -- -- 20.2M 80.8M 3.0M
Total Financing Cash Outflow 282.0M 568.0M 366.0M 160.0M 6.8M -- 850,000 13.0M 2.4M
Financing Cash Flow -273.0M -559.0M -362.0M 1.5B -6.8M -- 19.4M 67.8M 573,200
Net Change In Cash -416.0M -665.0M -197.0M 1.9B 223.0M 51.0M -31.3M 35.4M 5.5M
Ending Cash Balance 900.0M 1.3B 2.0B 2.2B 286.0M 62.9M 11.9M 43.3M 7.9M
Capex 221.0M 533.0M 270.0M 140.0M 37.1M 15.1M 34.7M 52.1M 2.1M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...